SOCAR and Comstock Resources Sign Letter of Intent for Strategic Partnership
SOCAR will acquire a 20% stake in Comstock's Legacy Haynesville assets, 15% in Western Haynesville assets, and 15% in Pinnacle Gas Services for $1.65B. The deal, targeting completion by Dec 2026, includes future partnership opportunities. SOCAR's stake in Western Haynesville will reduce to 7.5% upon a 15% return. Comstock will retain operational control and reduce debt. (CRK)
How this was made
The 30-second read
Why it matters
The transaction provides Comstock with liquidity and debt reduction while SOCAR gains a foothold in a prolific US gas basin, potentially reshaping regional supply dynamics.
Market read
A sizable cross‑border energy deal that could affect US gas supply, Comstock’s valuation, and broader M&A sentiment in the sector.
What to watch
Regulatory approvals and third‑party consents could delay closing, adding execution risk.
Background
SOCAR, Azerbaijan’s state‑owned energy company, is forming a strategic partnership with US‑listed Comstock Resources to acquire stakes in Haynesville shale assets.
Ticker impact
Comstock Resources agreed to sell $1.65 billion of Haynesville asset stakes to SOCAR, creating a strategic partnership.
CRK likely to rise on the news as investors value the debt reduction and cash infusion.
Large cash consideration and debt reduction are material catalysts; market typically rewards such strategic asset sales.
Market effects
US natural‑gas producers may see competitive pressure as SOCAR gains upstream exposure in Haynesville.
Azerbaijan’s SOCAR expands its footprint in North America, potentially influencing regional energy pricing.
The $1.65 bn transaction adds to global energy‑sector M&A activity, signaling continued capital deployment.
Counterpoint
If SOCAR’s capital commitment falters, the partnership could strain Comstock’s balance sheet and depress the stock.
Key entities
- CompanySOCAR
State‑owned Azerbaijani energy company expanding internationally.
- CompanyComstock Resources
US natural‑gas producer listed on NYSE under ticker CRK.
